[Twelve-week of sofosbuvir/velpatasvir therapeutic regimen for chronic hepatitis C patients in northwest region of China: a real-world multicenter clinical study]
【索非布韦/维帕他韦治疗方案在中国西北地区慢性丙型肝炎患者中的12周疗效：一项真实世界多中心临床研究】
期刊:Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
影响因子:
doi:10.3760/cma.j.cn501113-20201010-00548
Xu, Q; Zhang, W; Ma, Y X; He, C N; Zhang, L T; Abulitifu, Yilihamu; Li, Y; Wang, N; Wang, H L; Zhao, Y Y; Gao, X; Gao, P G; Su, X Y; Li, S; Liu, Y Y; Guo, F; Chen, Z Q; Liu, H L; Gao, X Q; Fu, J J; Yu, G Y; Wang, X Z; Wang, J P; Zhang, Y P; Ji, F P
